ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told

June 13, 1980

Ken Endicottm, Who Led NCI During “Golden Years,” Dies; Helped Establish Chemotherapy, Virology

July 24, 1987

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

May 25, 2007